For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...

Is it anxiety or a panic attack? Discover the key differences and learn why understanding them matters for managing your ...

The emergency department, while sophisticated and able to treat a variety of medical issues, is not always equipped to ...

J&J offers to buy ITCI for $14.6 billion. LLY announces disappointing preliminary sales numbers for the fourth quarter.

By establishing coding and separate payment for certain digital mental health devices, this group from CMS and the FDA hopes ...

Learn how quickly you can expect relief from Klonopin, a benzodiazepine medication commonly prescribed for anxiety and ...

I’ve lived with anxiety disorders for as long as I can remember. My sister has struggled with them too. Looking ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a clinical-stage neuropsychiatry company, summarized its 2024 accomplishments and detailed upcoming 2025 m ...

and serotonin norepinephrine reuptake inhibitors are indicated for generalized anxiety disorder. Cognitive behavioural therapy is a gold standard treatment for anxiety disorders in younger ...

Intra-Cellular Therapies’ performance in the stock market has been impressive, especially considering the broader market environment. The company’s stock is up +52.51% year-to-date (YTD), a remarkable ...